- Home
- PEV vs NERV Comparison
PEV vs NERV Comparison
Compare PEV & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEV
- NERV
- Stock Information
- Founded
- PEV 2002
- NERV 2007
- Country
- PEV United States
- NERV United States
- Employees
- PEV N/A
- NERV N/A
- Industry
- PEV Auto Manufacturing
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- PEV Consumer Discretionary
- NERV Health Care
- Exchange
- PEV Nasdaq
- NERV Nasdaq
- Market Cap
- PEV 15.4M
- NERV 18.3M
- IPO Year
- PEV 2022
- NERV 2014
- Fundamental
- Price
- PEV $0.35
- NERV $2.32
- Analyst Decision
- PEV
- NERV Hold
- Analyst Count
- PEV 0
- NERV 1
- Target Price
- PEV N/A
- NERV $5.00
- AVG Volume (30 Days)
- PEV 1.8M
- NERV 25.6K
- Earning Date
- PEV 11-19-2024
- NERV 11-05-2024
- Dividend Yield
- PEV N/A
- NERV N/A
- EPS Growth
- PEV N/A
- NERV N/A
- EPS
- PEV N/A
- NERV N/A
- Revenue
- PEV $21,635,000.00
- NERV N/A
- Revenue This Year
- PEV N/A
- NERV N/A
- Revenue Next Year
- PEV N/A
- NERV N/A
- P/E Ratio
- PEV N/A
- NERV N/A
- Revenue Growth
- PEV 324.30
- NERV N/A
- 52 Week Low
- PEV $0.32
- NERV $2.26
- 52 Week High
- PEV $1.60
- NERV $13.49
- Technical
- Relative Strength Index (RSI)
- PEV 35.35
- NERV 39.53
- Support Level
- PEV $0.37
- NERV $2.26
- Resistance Level
- PEV $0.40
- NERV $2.43
- Average True Range (ATR)
- PEV 0.05
- NERV 0.13
- MACD
- PEV -0.01
- NERV -0.01
- Stochastic Oscillator
- PEV 8.33
- NERV 8.77
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.